Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 3, 2013, Pages 228-234

  Stoodley, Paul W ^a,b   Richards, David A B ^c,d   Boyd, Anita ^d   Hui, Rina ^e   Harnett, Paul R ^e   Meikle, Steven R ^a,b   Clarke, Jillian L ^a,b   Thomas, Liza ^c,d,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Westmead Private Cardiology   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e Crown Princess Mary Cancer Centre   (Australia)

^f University of Sydney   (Australia)

Author keywords

Diastolic function; Two dimensional speckle tracking echocardiography (2DSTE): anthracyclines

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; EPIRUBICIN; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CARDIAC IMAGING; CARDIOTOXICITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TISSUE VELOCITY IMAGING; TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY;

ANTHRACYCLINES; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84874288322     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes139     Document Type: Article

References (21)

1. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 2008;26:3777-84.
2. Bird BR, Swain SM. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res 2008;14:14-24.
3. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339:900-5.
4. Jurcut R, Wildiers H, Ganame J, D'hooge J, De Backer J, Denys H et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 2008;21: 1283-9.
5. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol 2008;51:679-89.
6. Dorup I, Levitt G, Sullivan I, Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function. Heart 2004;90:1214-6.
7. Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 2006;7:141-6.
8. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation 2002;105:1503-8.
9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
10. Stoodley PW, Richards DA, Hui R, Boyd A, Harnett PR, Meikle SR et al. Twodimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. Eur J Echocardiogr 2011; 12:945-52.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
12. Dokainish H, Sengupta R, Pillai M, Bobek J, Lakkis N. Usefulness of new diastolic strain and strain rate indexes for the estimation of left ventricular filling pressure. Am J Cardiol 2008;101:1504-9.
13. Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ et al. Subclinical anthracycline-and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 2010;96:701-7.
14. Saghir M, Areces M, Makan M. Strain rate imaging differentiates hypertensive cardiac hypertrophy from physiologic cardiac hypertrophy (athlete's heart). J Am Soc Echocardiogr 2007;20:151-7.
15. Gilbert JC, Glantz SA. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res 1989;64:827-52.
16. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007;115:888-95.
17. Innelli P, Sanchez R, Marra F, Esposito R, Galderisi M. The impact of aging on left ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study. Eur J Echocardiogr 2008;9:241-9.
18. Tighe DA, Vinch CS, Hill JC, Meyer TE, Goldberg RJ, Aurigemma GP. Influence of age on assessment of diastolic function by Doppler tissue imaging. Am J Cardiol 2003;91:254-7.
19. Zuppinger C, Timolati F, Suter TM. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovasc Toxicol 2007;7:61-6.
20. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR, Seward JB. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 1994;69:212-24.
21. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.